Hostname: page-component-54dcc4c588-wlffp Total loading time: 0 Render date: 2025-10-03T06:33:11.976Z Has data issue: false hasContentIssue false
  • English
  • Français

Reviewer Comment on Slayter et al. “An Exploratory 12-Month Observational Study of Adults with Spinal Muscular Atrophy: Learning from Our Tools”

Published online by Cambridge University Press:  03 October 2025

Tiffany R. Price Open the ORCID record for Tiffany R. Price [Opens in a new window]  and
Jean K. Mah
Tiffany R. Price*
Affiliation:
Department of Pediatrics, Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada Collaboration for Outcomes Research and Evaluation (CORE), Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada
Jean K. Mah
Affiliation:
Department of Pediatrics, Alberta Children’s Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
*
Corresponding author: Tiffany R. Price; Email: tprice24@student.ubc.ca
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Information

Type
Reviewer Comment
Information
Canadian Journal of Neurological Sciences , First View , pp. 1
Copyright
© The Author(s), 2025. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Hagenacker, T, Maggi, L, Coratti, G, et al. Effectiveness of nusinersen in adolescents and adults with spinal muscular atrophy: systematic review and meta-analysis. Neurol Ther. 2024;13(5):1483–504. doi: 10.1007/s40120-024-00653-2.CrossRefGoogle ScholarPubMed
Walter, MC, Laforêt, P, van der Pol, WL, Pegoraro, E. 254th ENMC international workshop: formation of a european network to initiate a european data collection, along with development and sharing of treatment guidelines for adult SMA patients. Virtual meeting 28–30 January 2022.. Neuromuscul Disord. 2023;33(6):511–22. doi: 10.1016/j.nmd.2023.03.011.CrossRefGoogle ScholarPubMed
Price, TR, Hodgkinson, V, Westbury, G, et al. A study on the incidence and prevalence of 5q spinal muscular atrophy in Canada using multiple data sources. Can J Neurol Sci. 2024;51(5):660–71. doi: 10.1017/cjn.2024.1.CrossRefGoogle Scholar
Hodgkinson, VL, Chapman, K, Izenberg, A, et al. Response to provincial governments’ decisions regarding monitoring for adults with spinal muscular atrophy. Can J Neurol Sci. 2021;48(2):201–3. doi: 10.1017/cjn.2020.161.CrossRefGoogle ScholarPubMed
Vázquez-Costa, JF, Povedano, M, Nascimiento-Osorio, AE, et al. Validation of motor and functional scales for the evaluation of adult patients with 5q spinal muscular atrophy. Eur J Neurol. 2022;29(2):3666–75. doi: 10.1111/ene.15542.CrossRefGoogle ScholarPubMed
Slayter, J, Casey, L, Drost, D, McCullum, S, Christie, A, O’Connell, C. An exploratory 12-month observational study of adults with spinal muscular atrophy: learning from our tools. Can J Neurol Sci. 2025;15:1–29. doi: 10.1017/cjn.2025.10356. Epub ahead of print.CrossRefGoogle Scholar